Research & Development
One-third of U.S. adults with diabetes may have undetected cardiovascular disease
Researchers at Johns Hopkins University have generated evidence of how prevalent elevated levels of two biomarkers are in U.S. adults, with and without diabetes.
June 1, 2023
Lifespin debuts diagnostic service, an amino acid profiling panel
Analysis of the samples will be implemented by Lifespin at its sites in Germany and the U.S., and delivered to laboratory chain companies and healthcare providers as software-as-a-service.
May 22, 2023
Gene variant map helps diagnose hereditary diabetes
High-throughput experiments reveal connections between inherited disease and GCK gene variants, potentially providing better diagnoses of hereditary diabetes.
May 4, 2023
Blood-based biomarker score suggests lower type 2 diabetes risk with Mediterranean diet
Researchers have developed a blood test to objectively detect adherence to a Mediterranean diet and its association with lower type 2 diabetes risk.
May 1, 2023
Trinity Biotech selling life sciences supply business to Biosynth for $30M
Trinity Biotech said it pursued the transaction as part of its plan to focus on diabetes care and decentralized monitoring and diagnostic solutions.
April 20, 2023
Study of more than 600,000 people links COVID-19 infection to increase in diabetes diagnoses
The analysis, details of which were published in JAMA Network Open, looked at 629,935 people, 503,948 of whom tested negative for COVID-19.
April 18, 2023
University of Edinburgh researchers developing DNA methylation test to predict diabetes risk
The group has found that analyzing changes to DNA in a blood sample can help predict a person’s risk of developing type 2 diabetes within a decade.
April 7, 2023
Prediabetes self-screening via smartphone
If commercialized, a new system could enable people to self-screen for prediabetes on their smartphones, using modified commercially available test strips.
April 3, 2023
U.S. IVD market reaches $53 billion
According to Kalorama Information, the U.S. IVD market is projected to grow at a 2.4% average annual rate through 2027.
March 22, 2023
Gestational diabetes rise linked to screening practices
Although gestational diabetes is reportedly on the rise, a study finds that changes in screening practices may explain much of the increase.
March 20, 2023
DnaNudge, Mylab to develop MDx tests for diabetic foot infections, other health conditions
DnaNudge anticipates that its multiplex tests will enable health teams to identify the specific microbiological organisms responsible for each foot infection, providing antimicrobial resistance results in just over an hour.
March 13, 2023
GlycoMark prediabetes biomarker test validated in Swiss study
Glycomark, which has been cleared by the FDA and has been granted the CE Mark, is a nonfasting blood test that measures the biomarker 1,5-anhydroglucitol to identify individuals at greatest risk of progressing from prediabetes to type 2 diabetes.
February 22, 2023
Page 1 of 7